Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831. (Q36941405)
Jump to navigation
Jump to search
scientific article published on 12 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831. |
scientific article published on 12 April 2013 |
Statements
1 reference
Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831. (English)
1 reference
Amylou C Dueck
1 reference
Edith A Perez
1 reference
Jennifer A Crozier
1 reference
Alvaro Moreno-Aspitia
1 reference
Karla V Ballman
1 reference
Barbara A Pockaj
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference